1. Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event.
- Author
-
Martínez-Quintana E, Rodríguez-González F, Medina-Gil JM, Garay-Sánchez P, and Tugores A
- Subjects
- Acute Coronary Syndrome physiopathology, Aged, Cardiovascular Diseases etiology, Cardiovascular Diseases physiopathology, Coronary Artery Disease genetics, Coronary Artery Disease pathology, Coronary Disease physiopathology, Female, Follow-Up Studies, Genotype, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Polymorphism, Genetic, Retrospective Studies, Risk Factors, Severity of Illness Index, Acute Coronary Syndrome genetics, Aryldialkylphosphatase genetics, Cardiovascular Diseases genetics, Coronary Disease genetics
- Abstract
Introduction: Paraoxonase 1 (PON1) plays a major role in the oxidation of low density lipoprotein and in the prevention of coronary atherogenesis. In this context, coding region polymorphisms of PON1 gene, responsible for the enzyme activity, has become of interest as a marker for atherogenesis., Methods: A study and follow-up was conducted on 529 patients with an acute coronary event in order to assess the association between the PON1 Q192R (rs662;A/G) polymorphism, the type of acute coronary syndrome, cardiovascular risk factors (arterial hypertension, diabetes mellitus, dyslipidaemia, and smoking), the extent and severity of coronary atherosclerosis, and the medium-term clinical follow-up., Results: The QQ genotype was found in 245 (46.3%) patients, with 218 (41.2%) patients showing the QR genotype, and 66 (14.5%) patients had the RR genotype. No significant differences were found between the QQ and QR/RR genotypes as regards the clinical characteristics, the analytical data, and the angiographic variables. Similarly, Kaplan-Meier survival analysis showed no significant differences in presenting with a new acute coronary event (p=0.598), cardiac mortality (p=0.701), stent thrombosis (p=0.508), or stent re-stenosis (p=0.598) between QQ and QR/RR genotypes during the follow-up period (3.3±2.2 years)., Conclusions: In patients with an acute coronary syndrome, the PON1 Q192R genotypes did not influence the risk of suffering a new acute coronary event during the medium-term follow-up., (Copyright © 2016 Sociedad Española de Arteriosclerosis. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF